mycobacterium articles & resources on Made-in-China.com

Zep Has Agreed to Pay $905,000 to Resolve Alleged Violations of The Federal Insecticide

Aug 14, 2014

ATLANTA - Zep Inc., located in Atlanta, GA, has agreed to pay $905,000 to resolve alleged violations of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), the U.S. Environmental Protection Agency (EPA) announced today. As part ...

Tags: Zep, Alleged Violations, Service

Proteases Are Vital Proteins That Serve for Order Within Cells

Feb 13, 2014

Proteases are vital proteins that serve for order within cells. They break apart other proteins, ensuring that these are properly synthesized and decomposed. Proteases are also responsible for the pathogenic effects of many kinds of ...

Tags: Consumer Electronics, Electronics

Mullein Has Been Used for Centuries Because of Its Outstanding Medicinal Qualities

Nov 19, 2013

Mullein, a plant that grows in dry, barren places, has been used for centuries because of its outstanding medicinal qualities. Its healing properties are found in its roots, leaves, and flowers, and it has been effective in treating a ...

Tags: Mullein, medicinal qualities

US FDA Categorized Cepheid's Xpert Mtb/Rif Test

Aug 30, 2013

The U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert MTB/RIF test as 'moderate complexity' under the Clinical Laboratory Improvement Amendments (CLIA). Xpert MTB/RIF test is designed for the rapid molecular detection ...

Tags: moderate Complexity, Medicine

Cephid Received Market Authorization From The US FDA for MTB/Rif Test

Jul 26, 2013

Cepheid, a California-based medical device firm, has received market authorization from the US Food & Drug Administration (FDA) for its Xpert MTB/RIF test, a tuberclosis test. The regulatory agency approved following a de novo 510(k) ...

Tags: Cephid, Tuberclosis Test

Janssen Therapeutics Has Obtained Accelerated Approval From FDA for Sirturo Tablets

Jan 4, 2013

Janssen Therapeutics has obtained accelerated approval from FDA for Sirturo (bedaquiline) tablets as part of combination therapy to treat adult patients with pulmonary multi-drug resistant tuberculosis (MDR-TB). The surrogate endpoint of ...

Tags: Janssen Therapeutics, accelerated approval, FDA, Sirturo tablets

CE-Ivd Registration Is Won by Epistem Genedrive Tb Test

Dec 18, 2012

The biotechnology and personalized medicine company, Epistem, has gained CE mark for its in vitro diagnostic medical device (CE-IVD), Genedrive Tuberculosis (TB) test. Epistem said the registration enables to place its TB test and ...

Tags: Epistem, CE mark, CE-IVD, diagnostic medical device, TB test

Veredus Laboratories Introduced a Multiplexed Molecular Diagnostic Platform

Dec 7, 2012

Veredus Laboratories, a Singapore-based subsidiary of STMicroelectronics, has introduced a multiplexed molecular diagnostic platform for identifying the specific mycobacterium causing the infection and drug resistance. The VereMTB ...

Tags: Veredus, diagnostic platform, mycobacterium, drug resistance

Janssen-Cilag International Submitted a Marketing Authorisation Application

Dec 5, 2012

Janssen-Cilag International has submitted a Marketing Authorisation Application to the European Medicines Agency (EMA) seeking conditional approval to use the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as ...

Tags: investigational drug bedaquiline, multi-drug resistant tuberculosis

LabCorp Uses B-Smart to Develop a New Laboratory-Based Antibiotic Susceptibility Assay

Dec 4, 2012

Sequella has licensed its B-SMART technology to Laboratory Corporation of America (LabCorp) to allow LabCorp to develop a new laboratory-based antibiotic susceptibility assay for Mycobacterium tuberculosis and to use the assay in the US ...

Tags: LabCorp, B-SMART technology, Sequella

Janssen Submits Bedaquiline (TMC207) New Drug Application (Nda) to FDA for Approval.

Dec 4, 2012

Janssen Research & Development company has submitted bedaquiline (TMC207) new drug application (NDA) to the US Food and Drug Administration (FDA) for approval. Bedaquiline,an investigational drug administered orally,is used as part of ...

Tags: FDA, new drug application, investigational drug, pulmonary

mycobacterium

Related Products